Cargando…

Assessment of vaccine candidates for persons aged 50 and older: a review

BACKGROUND: The increasing life expectancy in most European countries has resulted in growth of the population 50 and older. This population is more susceptible to infectious diseases because of immunosenescence, co-morbidity and general frailty. Thus, to promote healthy aging, vaccination against v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eilers, Renske, Krabbe, Paul FM, van Essen, Ted GA, Suijkerbuijk, Anita, van Lier, Alies, de Melker, Hester E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668232/ https://www.ncbi.nlm.nih.gov/pubmed/23586926 http://dx.doi.org/10.1186/1471-2318-13-32

Ejemplares similares

Motives of Dutch persons aged 50 years and older to accept vaccination: a qualitative study
por: Eilers, Renske, et al.
Publicado: (2015)

Attitudes of Dutch general practitioners towards vaccinating the elderly: less is more?
por: Eilers, Renske, et al.
Publicado: (2015)

The intention of Dutch general practitioners to offer vaccination against pneumococcal disease, herpes zoster and pertussis to people aged 60 years and older
por: Lehmann, Birthe A., et al.
Publicado: (2017)

Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2010)

Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines
por: de Boer, Pieter T., et al.
Publicado: (2018)

Intention to vaccinate universally against varicella, rotavirus gastroenteritis, meningococcal B disease and seasonal influenza among parents in the Netherlands: an internet survey
por: van Lier, Alies, et al.
Publicado: (2017)

Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster
por: van Lier, Alies, et al.
Publicado: (2015)

Negative attitude and low intention to vaccinate universally against varicella among public health professionals and parents in the Netherlands: two internet surveys
por: van Lier, Alies, et al.
Publicado: (2016)

Hospitalization due to varicella in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2011)

Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020
por: Middeldorp, Marit, et al.
Publicado: (2021)

Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2019)

Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011
por: van Lier, Alies, et al.
Publicado: (2016)

Healthcare workers’ perceptions and experiences of communicating with people over 50 years of age about vaccination: a qualitative evidence synthesis
por: Glenton, Claire, et al.
Publicado: (2021)

Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012
por: Sane, Jussi, et al.
Publicado: (2014)

Vaccines for Women Age 50 and Older
por: Gardner, Pierce, et al.
Publicado: (2004)

A qualitative study of parental associations and beliefs regarding the HPV vaccination for Dutch boys
por: Venderbos, Judith R., et al.
Publicado: (2022)

Performance And Agreement Of Risk Stratification Instruments For Postoperative Delirium In Persons Aged 50 Years Or Older
por: Jansen, Carolien J., et al.
Publicado: (2014)

The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands
por: McDonald, Scott A, et al.
Publicado: (2012)

Economic Costs of Measles Outbreak in the Netherlands, 2013–2014
por: Suijkerbuijk, Anita W.M., et al.
Publicado: (2015)

Determinants of HPV-vaccination uptake and subgroups with a lower uptake in the Netherlands
por: de Munter, A. C., et al.
Publicado: (2021)

Gender-specific mortality in DTP-IPV- and MMR ± MenC-eligible age groups to determine possible sex-differential effects of vaccination: an observational study
por: Schurink-van’t Klooster, Tessa M, et al.
Publicado: (2015)

Mumps Vaccine Effectiveness Against Orchitis
por: Hahné, Susan, et al.
Publicado: (2012)

Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study
por: Swart, E. M., et al.
Publicado: (2016)

Focus group study on perceptions and information needs regarding vaccines targeting the older population: a cross-country comparison in four European countries
por: Wennekes, Manuela Dominique, et al.
Publicado: (2022)

Plant expression and characterization of the transmission-blocking vaccine candidate PfGAP50
por: Beiss, Veronique, et al.
Publicado: (2015)

Impact of personality functioning and pathological traits on mental wellbeing of older patients with personality disorders
por: Veenstra, Martine S., et al.
Publicado: (2022)

Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country
por: Suijkerbuijk, Anita W. M., et al.
Publicado: (2018)

Pneumococcal vaccination in older persons: where are we today?
por: Van Buynder, Paul, et al.
Publicado: (2018)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals
por: Knol, Mirjam J, et al.
Publicado: (2022)

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older
por: Schwarz, Tino F, et al.
Publicado: (2017)

An exploratory qualitative assessment of factors influencing childhood vaccine providers' intention to recommend immunization in the Netherlands
por: Mollema, Liesbeth, et al.
Publicado: (2012)

Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands
por: Thorrington, Dominic, et al.
Publicado: (2018)

Effect of the bivalent HPV vaccine on viral load of vaccine and non-vaccine HPV types in incident clearing and persistent infections in young Dutch females
por: van der Weele, Pascal, et al.
Publicado: (2019)

2656. Eliciting Preferences for Zoster Vaccination in US Adults Aged 50 Years and Older
por: Patterson, Brandon J, et al.
Publicado: (2019)

Determinants of COVID-19 Vaccine Uptake in The Netherlands: A Nationwide Registry-Based Study
por: Pijpers, Joyce, et al.
Publicado: (2023)

Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule
por: Hoes, Joske, et al.
Publicado: (2021)

Dutch Perspectives Toward Governmental Trust, Vaccination, Myths, and Knowledge About Vaccines and COVID-19
por: Yousuf, Hamza, et al.
Publicado: (2021)

Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
por: Knol, Mirjam J, et al.
Publicado: (2018)

A media intervention applying debunking versus non-debunking content to combat vaccine misinformation in elderly in the Netherlands: A digital randomised trial
por: Yousuf, Hamza, et al.
Publicado: (2021)

Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older
por: Curran, Desmond, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kl1lsej53ck9a5ouq7ira0d5np